Literature DB >> 7559405

Identification of a new subclass of Alu DNA repeats which can function as estrogen receptor-dependent transcriptional enhancers.

J Norris1, D Fan, C Aleman, J R Marks, P A Futreal, R W Wiseman, J D Iglehart, P L Deininger, D P McDonnell.   

Abstract

We have utilized a genetic selection system in yeast to identify novel estrogen-responsive genes within the human genome and to define the sequences in the BRCA-1 gene responsible for its estrogen responsiveness. This approach led to the identification of a new subclass within the Alu family of DNA repeats which have diverged from known Alu sequences and have acquired the ability to function as estrogen receptor-dependent enhancers. Importantly, these new elements confer receptor-dependent estrogen responsiveness to a heterologous promoter when assayed in mammalian cells. This transcriptional activity can be attenuated by the addition of either of three different classes of estrogen receptor antagonists, indicating that these elements function as classical estrogen receptor-dependent enhancers. Furthermore, this enhancer activity is restricted to a specific subset of DNA repeats because consensus Alu elements of four major subfamilies do not respond to the estrogen receptor. Previously, most Alu sequences have been considered to be functionally inert. However, this work provides strong evidence that a significant subset can confer estrogen responsiveness upon a promoter within which they are located. Clearly, Alu sequences must now be considered as important contributors to the regulation of gene transcription in estrogen receptor-containing cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7559405     DOI: 10.1074/jbc.270.39.22777

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  67 in total

Review 1.  BRCA1 and BRCA2 proteins: roles in health and disease.

Authors:  J A Duncan; J R Reeves; T G Cooke
Journal:  Mol Pathol       Date:  1998-10

2.  Sequence comparison of human and mouse genes reveals a homologous block structure in the promoter regions.

Authors:  Yutaka Suzuki; Riu Yamashita; Matsuyuki Shirota; Yuta Sakakibara; Joe Chiba; Junko Mizushima-Sugano; Kenta Nakai; Sumio Sugano
Journal:  Genome Res       Date:  2004-09       Impact factor: 9.043

3.  Comparative analysis of Alu insertion sequences in the APP 5' flanking region in humans and other primates.

Authors:  Jordi Clarimón; Aida M Andrés; Jaume Bertranpetit; David Comas
Journal:  J Mol Evol       Date:  2004-06       Impact factor: 2.395

Review 4.  The role of Alu elements in the cis-regulation of RNA processing.

Authors:  Chammiran Daniel; Mikaela Behm; Marie Öhman
Journal:  Cell Mol Life Sci       Date:  2015-07-30       Impact factor: 9.261

5.  Computational method for discovery of estrogen responsive genes.

Authors:  Suisheng Tang; Sin Lam Tan; Suresh Kumar Ramadoss; Arun Prashanth Kumar; Man-Hung Eric Tang; Vladimir B Bajic
Journal:  Nucleic Acids Res       Date:  2004-12-01       Impact factor: 16.971

6.  Age- and cell cycle-dependent changes in EPC-1/PEDF promoter activity in human diploid fibroblast-like (HDF) cells.

Authors:  Toshihiko Kojima; Ken-ichi Nakahama; Kiyotaka Yamamoto; Hiroshi Uematsu; Ikuo Morita
Journal:  Mol Cell Biochem       Date:  2006-07-31       Impact factor: 3.396

7.  WNT11 expression is induced by estrogen-related receptor alpha and beta-catenin and acts in an autocrine manner to increase cancer cell migration.

Authors:  Mary A Dwyer; James D Joseph; Hilary E Wade; Matthew L Eaton; Rebecca S Kunder; Dmitri Kazmin; Ching-yi Chang; Donald P McDonnell
Journal:  Cancer Res       Date:  2010-09-24       Impact factor: 12.701

8.  Estrogen-related receptor alpha induces the expression of vascular endothelial growth factor in breast cancer cells.

Authors:  Rebecca A Stein; Stéphanie Gaillard; Donald P McDonnell
Journal:  J Steroid Biochem Mol Biol       Date:  2009-03-03       Impact factor: 4.292

9.  Yeast RSP5 and its human homolog hRPF1 potentiate hormone-dependent activation of transcription by human progesterone and glucocorticoid receptors.

Authors:  M O Imhof; D P McDonnell
Journal:  Mol Cell Biol       Date:  1996-06       Impact factor: 4.272

10.  A prospective study of genetic polymorphism in MPO, antioxidant status, and breast cancer risk.

Authors:  Chunyan He; Rulla M Tamimi; Susan E Hankinson; David J Hunter; Jiali Han
Journal:  Breast Cancer Res Treat       Date:  2008-03-14       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.